am 580 and krn 7000

am 580 has been researched along with krn 7000 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Browne, PV; Doherty, DG; Ghnewa, YG; McElligott, AM; O'Reilly, VP; Vandenberghe, E1

Other Studies

1 other study(ies) available for am 580 and krn 7000

ArticleYear
Retinoic acid induction of CD1d expression primes chronic lymphocytic leukemia B cells for killing by CD8
    Clinical immunology (Orlando, Fla.), 2017, Volume: 183

    Topics: Aged; Aged, 80 and over; Antigen Presentation; Antigens, CD1d; Antineoplastic Agents; B-Lymphocytes; Benzoates; CD8-Positive T-Lymphocytes; Female; Galactosylceramides; Humans; In Vitro Techniques; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Natural Killer T-Cells; Retinoic Acid Receptor alpha; Tetrahydronaphthalenes; Tretinoin

2017